21 - 22 June 2018 / Barcelona, Spain

Agenda

The event agenda's time zone is CEST.

Thu
21 Jun 2018
08:30 – 09:15
Main hall
Registration

Please provide valid photo ID.

09:15 – 09:35
Auditorium
Institutional opening
  • Jordi Naval, Director of Strategy, Biocat.
  • Roland Bugat, ONCONET SUDOE scientific coordinator, University Toulouse III Paul Sabatier. 
  • Lourdes Núñez. Director of Knowledge Transfer, Internationalization and Entrepreneurship, Fundación Pública Andaluza Parque Tecnológico de la Salud de Granada (PTS Granada). Onconet WP4 leader.
09:35 – 10:15
Auditorium
Keynote session: Translational cancer research

Joaquín Arribas. Scientific Director, Vall d'Hebron Institute of Oncology (VHIO).

10:15 – 11:30
Auditorium
Plenary session 1: Innovative therapeutic approaches in oncology

Patients have seen their life expectancy increase due to a growing number of therapeutic targets over the past years. Most of them attack the progression of cancer in a personalized manner, guiding the path for a new cancer treatment paradigm, which is the main topic to be discussed in this session.

Chair: Ana Bela Sarmento. Group Leader at CIMAGO, Faculty of Medicine of the University of Coimbra.

Speakers:

  • Laura Soucek. Founder and Chief Scientific Officer, Peptomyc.
  • José Manuel Nascimento Costa. Director of University Clinic of Oncology, Faculty of Medicine of the University of Coimbra (FMUC).
  • Pedro Sánchez Rovira. Oncology Unit Director, Hospital de Jaén.
  • Antonio Viudez. Second Director, Hospital Complex of Navarre.
10:20 – 14:00
Partnering Area
One2One meetings

Check this session if you want to offer availability during Thursday Morning 

Break
11:30 – 12:00
Main hall
Coffee break
12:00 – 13:10
Auditorium
Plenary session 2 - Reimbursment and market access to oncology treatments

Oncology treatments are known for their high research and production costs. Taken in addition to the diversity of European healthcare systems, several issues can rise, like varying degrees of patient access to oncology treatments or how innovative companies get reimbursed the drug cost and/or value.

Chair to be confirmed.

Speakers:

  • José Antonio Lopes Feio. Director of Pharmaceutical Services, Centro Hospitalar e Universitário de Coimbra (CHUC).
  • Caridad Pontes García. Lead of Pharmacotherapeutic Harmonization, Catalan Health Service (CatSalut).

Additional speakers to be confirmed.

Breakout sessions
13:15 – 13:45
Room 1
Introductory session 1 I Needs of children and teenagers with cancer

The session chair will lay the groundwork for the brainstorming challenge session at 3.15 pm, introducing the topic, presenting future goals and solutions already explored.

Chair: Jaume Mora Graupera. Scientific Director of the Pediatric Hemato-Oncology, Hospital Sant Joan de Déu (SJD) Barcelona.

Moderator: Emilia Ventel. Project Manager, University Toulouse III - Paul Sabatier.

Breakout sessions
13:15 – 13:45
Room 2
Introductory session 2 I Biomarkers and liquid biopsy for P4 oncology

This session chair will lay the groundwork for the brainstorming challenge session at 3.15 pm, introducing the topic, presenting future goals and solutions already explored. 

Chair: Roger Gomis. ICREA Research Professor, Head of Metastasis Laboratory, Institute for Research in Biomedicine of Barcelona (IRB Barcelona).

Moderator: Arantxa Ibarrola Segura. Project Manager, Navarrabiomed.

Breakout sessions
13:15 – 13:45
Room 3
Introductory Session 3 I Telemedicine, mHealth and healthy habits for oncology patients

An increasing number of patients survive cancer. Telemedicine supports the use of medical, clinical and administrative information exchanged electronically from one site to another to improve a patient’s clinical health status. These exchanges should permit better patient management, an improvement in patient care/services and greater communication between patients and health specialists that eventually might turn into patient empowerment. E-health interventions have shown to be efficacious to decrease fat intake and increase fruit and vegetable intake, while other interventions centered in self-monitoring of body weight and nutrition/life styles related behaviors. E-Health literacy has become an up-to-date concept. Indeed, we need to acknowledge that internet and new technologies are “here for good” and health promotion needs to update its interventions for several health behaviours, with potential major benefits.

By the Chair Paula Ravasco.


The session chair will lay the groundwork for the brainstorming challenge session at 3.15 pm, introducing the topic, presenting future goals and solutions already explored.


Chair: Paula Ravasco. Professor, University Hospital of Santa Maria - University of Lisbon - Centre for Interdisciplinary Research in Health of the Portuguese Catholic University.

Moderator: Mireia Félez. Project Manager for Onconet, Catalan Institute of Oncology (ICO).

Break
13:45 – 15:15
Conference hall
LUNCH + POSTERS
15:00 – 17:40
Partnering Area
One2One meetings

Check this session if you want to offer availability during Thursday evening 

Breakout sessions
15:15 – 17:15
Room 1
Brainstorming challenge 1 I Needs of children and teenagers with cancer

Join an exciting multidisciplinary discussion to identify future challenges and assess potential solutions. We will use discussion-based methodology and you will be able to interact with all 25 participants in the group. 

Chair: Jaume Mora Graupera. Scientific director of the Oncology and Hematology Area, Sant Joan de Déu (SJD) Barcelona Children's Hospital.

Moderator: Emilia Ventel. Project Manager, University Toulouse III - Paul Sabatier.

Breakout sessions
15:15 – 17:15
Room 2
Brainstorming Challenge 2 I Biomarkers and liquid biopsy for P4 oncology

Join an exciting multidisciplinary discussion to identify future challenges and assess potential solutions. We will use discussion-based methodology and you will be able to interact with all 25 participants in the group. 

Chair: Roger Gomis. Group Leader, Growth control and cancer metastasis, Institute for Research in Biomedicine (IRB).

Moderator: Arantxa Ibarrola Segura. Project Manager, Navarrabiomed.

Featured participants:

  • Pierre Cordelier. Research Director, Institut national de la santé et de la recherche médicale (INSERM).
  • David Guerrero-Setas. Principal investigator in cancer epigenetics research group, Navarrabiomed-FMS.
Breakout sessions
15:15 – 17:15
Room 3
Brainstorming Challenge 3 I Telemedicine, mHealth and healthy habits for oncologic patients

Join an exciting multidisciplinary discussion to identify future challenges and assess potential solutions. We will use discussion-based methodology and you will be able to interact with all 25 participants in the group. 


Chair: Paula Ravasco. Professor, University Hospital of Santa Maria - University of Lisbon - Centre for Interdisciplinary Research in Health of the Portuguese Catholic University, Portugal.

Moderator: Mireia Félez. Project Manager for Onconet, Catalan Institute of Oncology (ICO).

Featured Participants

  • Emmanuel Sicard. CEO, MHComm.
  • Juan Ignacio Arrarás. Principal Investigator in research group Quality of Life from oncology patients inside EORTC, Navarrabiomed-FMS.
  • Cristian Ochoa. Psycho-oncologist, Catalan Institute of Oncology (ICO) - Bellvitge Biomedical Research Institute (IDIBELL).
15:15 – 16:15
Auditorium
Scientific session 1: Future omic tools in oncology: genomics bioinformatics and epigenetics

The scientific sessions will dissect oncology challenges currently up for debate in the battle against cancer, thearing from renowned researchers from the ONCONET SUDOE consortium.

Chair: Manel Esteller Badosa. ICREA Research Professor, IDIBELL, Bellvitge Biomedical Research Institute.

Speakers:

  • Enrique Carrillo. Head of Computational Biology Group, IMDEA Research Institute on Food & Health Sciences.
  • Miquel Angel Pujana. Director Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, IDIBELL. 
  • Pedro Carmona Sáez. Bioinformatics Unit Head, Center for Genomics and Oncological Research (GENyO).
16:15 – 17:15
Auditorium
Scientific session 2: Tumor micro environment in cancer progression

The scientific sessions will dissect oncology challenges currently up for debate in the battle against cancer, hearing from renowned researches from the ONCONET SUDOE consortium 

Chair: Salvador Aznar. Group leader Stem Cells, European Research Council (ERC).

Speakers:

  • Luís Costa. Director of Oncology Division, Hospital de Santa Maria – Centro Hospitalar Lisboa Norte.
  • Oriol Casanovas. Head of Tumor Angiogenesis Group, Catalan Institute of Oncology (ICO) - Bellvitge Biomedical Research Institute (IDIBELL).
  • Catherine Muller. Group Leader, Institute of Pharmacology and of Structural Biology.
  • Juan Carlos Rodríguez Manzaneque. Proteases and Extracellular Matrix Group Leader, Centre for Genomics and Oncological Research (GENyO).
Break
17:15 – 17:45
Coffee break
17:45 – 18:15
Auditorium
Brainstorming wrap-up

Results from Brainstorming challenges will be presented by session chairs.

20:00 – 22:30
PRBB
Evening reception

Buses will be available from Fira Barcelona GranVia starting at 7.30 pm.

Return buses will be available from PRBB until 10.45 pm.

Participants must sign up for this session in advance. Event ID badge will be required to enter the reception venue.

Fri
22 Jun 2018
09:00 – 11:40
Partnering Area
One2One meetings

Check this session if you want to offer partnering availability during Friday Morning

09:30 – 09:40
Auditorium
Word of welcome

Director of Innovation, Biocat.

09:40 – 11:00
Auditorium
Plenary session 3 - How patients, researchers and clinicians can go into policymaking to foster RRI

The diversity of stakeholders involved in developing new technology to fight cancer hinders the creation of public policies that balance all of their expectations. Nevertheless, the alignment of R&D and Healthcare policies is essential for a successful path to beating cancer.

Chair: Michela Bertero. Head of Internationalization and Scientific Affairs, Centre for Genomic Regulation (CRG). Orion Project.

Speakers:

  • Pastora Martínez. Vice President for Globalization and Cooperation, Open University of Catalonia (UOC).
  • Mª Dolors Navarro Rubio. Director of the Patient Experience Department, Sant Joan de Déu (SJD) Barcelona Children’s Hospital.
  • José Expósito Hernández. Director of the Oncology Unit, Virgen de las Nieves University Hospital.
  • Fernando Regateiro. Director of Administrative Council, Centro Hospitalar e Universitário de Coimbra (CHUC).
  • Concepción Biurrun. Treasurer and representative, Saray (Asociación Navarra de Cancer de Mama).
Break
11:00 – 11:40
Hall
Coffee break
11:40 – 13:30
Auditorium
TECH TRANSFER COMPETITION

The TECH TRANSFER COMPETITION features 12 cherry-picked entrepreneurs, TTO or principal investigators that are developing new technology from a research entity that is ready to be licensed or has begun development through a spin-off. 

Selected participants will present their innovative projects in a 7-minute pitch to an experienced panel of judges.

Presented by: Roi Villar. Head of Internationalization, Biocat.

Panel of judges:

  • Director of Innovation, Biocat.
  • Jean-Pierre Saintouil. President of Bio Compass, Toulouse. 
  • Lourdes Núñez Müller. Director of Knowledge Transfer, Internationalization and Entrepreneurship, Fundación Pública Andaluza Parque Tecnológico de la Salud de Granada (PTS Granada).

13:30 – 14:00
Auditorium
INSTITUTIONAL CLOSING

This session will feature the award ceremony for the OncoTRANSFER COMPETITION.

  • Jordi Naval. Director of Strategy, Biocat.
  • Roland Bugat. Director of Onco-Résonanece, Institut Universitaire du Cancer de Toulouse Oncopole (IUCT Oncopole). Onconet Scientific Coordinator.
  • Lourdes Núñez. Director of Knowledge Transfer, Internationalization and Entrepreneurship, Fundación Pública Andaluza Parque Tecnológico de la Salud de Granada (PTS Granada). Onconet WP4 leader.